Top upgrades and downgrades on 7/7: KSS, BG, GTLB, PATH and more

Analysts Notebook wrote a column · Jul 7, 2022 20:17

Upgrades

• $Allegiance (ABTX.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $43

• $Bunge (BG.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $106 (from $130)

• $Cerence (CRNC.US)$ : RBC Capital Upgrades to Sector Perform from Underperform - PT $27 (from $28)

• $First Mid Bancshares (FMBH.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $45

• $Lamar Advertising Co (LAMR.US)$ : Citigroup Upgrades to Buy from Neutral - PT $108 (from $112)

• $Pinnacle Financial Partners (PNFP.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $85

• $Pacific Premier Bancorp (PPBI.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $35 (from $41)

• $PPL Corp (PPL.US)$ : Evercore Upgrades to Outperform from In Line - PT $30 (from $31)

• $Champion Homes (SKY.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $70

• $Texas Capital Bancshares (TCBI.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $70

Downgrades

• $Aspen Technology (AZPN.US)$ : Baird Downgrades to Neutral - PT $162 (from $170)

• $Pathward Financial (CASH.US)$ : Raymond James Downgrades to Outperform from Strong Buy - PT $46 (from $70)

• $Dime Community Bancshares Inc (DCOM.US)$ : Raymond James Downgrades to Outperform from Strong Buy - PT $34 (from $41)

• $Kohl's Corp (KSS.US)$ : BofA Securities Downgrades to Underperform from Neutral - PT $26 (from $50)

• $Kellanova (K.US)$ : UBS Downgrades to Neutral from Buy - PT $74 (from $81)

• $Otis Worldwide (OTIS.US)$ : JPMorgan Downgrades to Neutral from Overweight - PT $62 (from $100)

• $Bank OZK (OZK.US)$ : Wells Fargo Downgrades to Equal Weight from Overweight - PT $42 (from $58)

• $Boston Beer (SAM.US)$ : RBC Capital Downgrades to Sector Perform from Outperform - PT $331 (from $488)

• $Sealed Air (SEE.US)$ : BofA Securities Downgrades to Neutral from Buy - PT $67 (from $82)

• $Veritex (VBTX.US)$ : Raymond James Downgrades to Outperform from Strong Buy - PT $38

Initiated

• $Datadog (DDOG.US)$ : Canaccord initiates at Hold - PT $120

• $Duolingo (DUOL.US)$ : Needham initiates at Buy - PT $115

• $Elastic (ESTC.US)$ : Canaccord initiates at Buy - PT $100

• $JFrog (FROG.US)$ : Canaccord initiates at Buy - PT $30

• $Gitlab (GTLB.US)$ : Needham initiates at Buy - PT $70

• $Harmony Biosciences (HRMY.US)$ : Mizuho Securities initiates at Buy - PT $64

• $Intra-Cellular Therapies (ITCI.US)$ : Mizuho Securities initiates at Buy - PT $74

• $New Relic (NEWR.US)$ : Canaccord initiates at Buy - PT $81

• $UiPath (PATH.US)$ : Canaccord initiates at Buy - PT $25

• $Splunk (SPLK.US)$ : Canaccord initiates at Buy - PT $130

Moomoo Inc. ("moomoo") provides mobile and online technology solutions for securities trading. Moomoo is not an investment adviser or a broker-dealer and it provides neither investment or financial advice nor securities trading services. All contents such as comments and links posted or shared by users of the community are opinions of the respective authors only and do not reflect the opinions, views, or positions of moomoo, its affiliates, or any employees of moomoo or its affiliates. Please consult a qualified investment or tax advisor for your personal financial planning and tax situations.

Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more

Translate

Report

510K Views

Comment

Analysts Notebook

Moomoo News Official Account

How do analysts evaluate the market?

19KFollowers

46Following

39KVisitors